POLBF (Poolbeg Pharma) Total Liabilities : $0.71 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Poolbeg Pharma Total Liabilities?

Poolbeg Pharma's Total Liabilities for the quarter that ended in Jun. 2024 was $0.71 Mil.

Poolbeg Pharma's quarterly Total Liabilities increased from Jun. 2023 ($0.65 Mil) to Dec. 2023 ($1.25 Mil) but then declined from Dec. 2023 ($1.25 Mil) to Jun. 2024 ($0.71 Mil).

Poolbeg Pharma's annual Total Liabilities increased from Dec. 2021 ($0.58 Mil) to Dec. 2022 ($1.18 Mil) and increased from Dec. 2022 ($1.18 Mil) to Dec. 2023 ($1.25 Mil).

Poolbeg Pharma Total Liabilities Historical Data

The historical data trend for Poolbeg Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Total Liabilities Chart

Poolbeg Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Total Liabilities

0.58

1.18

1.25

Poolbeg Pharma Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Liabilities	Get a 7-Day Free Trial			1.02	1.18	0.65	1.25	0.71

Poolbeg Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Poolbeg Pharma's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.248	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	1.25

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	19.529	-	18.281
	=	1.25

Poolbeg Pharma's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.714	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	0.71

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	16.552	-	15.838
	=	0.71

Poolbeg Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Poolbeg Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (OTCPK:POLBF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

POLB:UK 7JN:Germany

Address

42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.poolbegpharma.com

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.